Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Translation dysregulation in cancer as a source for targetable antigens

Cancer Cell(2025)10.1016/j.ccell.2025.03.003Source: DataRank Database

Translation dysregulation in cancer as a source for targetable antigens is a research paper published in Cancer Cell (2025). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (29 grants)Impact (FWCI 9.37)OA: hybridTopics (50)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (47)

Osnat Bartok,Christopher S. McGinnis ORCID,Heyilimu Palashati ORCID,Tiangen Chang ORCID,Dmitry B. Malko ORCID

Live enrichment

PubMed:40154482 PMC:PMC12074880 OpenAlex:https://openalex.org/W4408967828

Israel Science Foundation

Grant: 2133/23

European Commission

Grant: 101094980

An integrative genetic approach for the exploration of melanoma immunological interactions

Novo Nordisk Fonden

Grant: GM136960

Israel Cancer Research Fund

Grant: 20-802-ICG

Cancer Research Institute

Grant: 4134

Exploratory Research for Advanced Technology

Grant: JPMJER2002

Horizon 2020 Framework Programme

Grant: 770854

An integrative approach for the exploration of melanoma genetic and immunological interactions

Norges Forskningsråd

Grant: 332727

PRIMA - Precision Immunotherapy Alliance

Norges Forskningsråd

Grant: 316060

Donor T-cell receptors targeting cells that propagate cancer

Melanoma Research Alliance

Grant: 917324

Helse Sør-Øst RHF

Grant: 865805

Outsourcing cancer immunity to healthy donors

Helse Sør-Øst RHF

Grant: 2021074

Kreftforeningen

Grant: 216135-2020

NCI NIH HHS

Grant: K99 CA293137

NIGMS NIH HHS

Grant: R01 GM136960

Intramural NIH HHS

Grant: ZIA HG200337

Intramural NIH HHS

Grant: Z01 HG200337

National Institutes of Health

Grant: 5R01GM136960-02

The role of collisions in rescuing stalled ribosomes in bacteria

Novo Nordisk Foundation

Grant: unidentified

unidentified

Minerva Foundation

Burroughs Wellcome Fund

National Cancer Institute

Horizon 2020

Parker Institute for Cancer Immunotherapy

European Research Council

Support Center for Advanced Telecommunications Technology Research Foundation

Bundesministerium für Bildung und Forschung

National Institutes of Health

Japan Science and Technology Agency

FWCI

9.37

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ccell.2025.03.003

publisherhttps://doi.org/10.1016/j.ccell.2025.03.003

publisherhttps://api.elsevier.com/content/article/PII:S1535610825000820?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610825000820?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40154482

Fields of Study

RNA and protein synthesis mechanismsRNA modifications and cancerRNA Research and Splicing03 medical and health sciences0302 clinical medicineHumansAnimalsProtein BiosynthesisMiceNeoplasmsAntigens, NeoplasmCell Line, TumorImmunotherapyProgrammed Cell Death 1 ReceptorImmune Checkpoint Inhibitors

MeSH Terms

Immune Checkpoint InhibitorsAnimalsAntigens, NeoplasmHumansImmunotherapyNeoplasmsProtein BiosynthesisCell Line, TumorMiceProgrammed Cell Death 1 Receptor

Keywords

Translation (biology)AntigenCancerCancer researchBiologyImmunologyMedicineGeneticsGeneMessenger RNAImmune Checkpoint BlockadeNeoantigensTranslation FidelityNon-canonical PeptidesCancer ImmunopeptidomeMiceAntigens, NeoplasmProtein BiosynthesisNeoplasmsCell Line, TumorProgrammed Cell Death 1 ReceptorHumansAnimalsImmunotherapyImmune Checkpoint Inhibitors